{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:41:55Z","timestamp":1778326915984,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T00:00:00Z","timestamp":1503014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T00:00:00Z","timestamp":1503014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Metabonomics\/metabolomics is a rapid technology for comprehensive profiling of small molecule metabolites in cells, tissues, or whole organisms, the application of which has led to understanding pathophysiologic mechanisms of cardiometabolic diseases, defining predictive biomarkers for those diseases, and also assessing the efficacious effects of incident drugs. In this study, proton nuclear magnetic resonance (NMR)-based metabonomics was employed to identify the metabolic changes in rat plasma caused by myocardial ischemia-reperfusion injury (MIRI), and to compare the metabolic regulatory differences between traditional Chinese medicine Wenxin Keli (WXKL) and Western medicine verapamil. The results revealed that energy-substrate metabolism were significantly disturbed by ischemia-reperfusion (I\/R) in myocardium and bulk of the key metabolites could be further modulated by verapamil and\/or WXKL. Lipid metabolism and amino acid transamination occurred mainly following the treatment of verapamil, whereas glucose oxidation and BCAA degradation were prominently ameliorated by WXKL to content the energy demands of heart. Moreover, both WXKL and verapamil improved the secretions of taurine and ketone bodies to overcome the oxidative stress and the shortage of energy sources induced by ischemia-reperfusion.<\/jats:p>","DOI":"10.1038\/s41598-017-09547-w","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T11:01:27Z","timestamp":1502708487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparative metabonomics of Wenxin Keli and Verapamil reveals differential roles of gluconeogenesis and fatty acid \u03b2-oxidation in myocardial injury protection"],"prefix":"10.1038","volume":"7","author":[{"given":"Miaomiao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingrui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanwei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,18]]},"reference":[{"key":"9547_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers, C. D. & Loncar, D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med \n                           3, e442 (2006).","journal-title":"PLoS Med"},{"key":"9547_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1023\/A:1006808507605","volume":"186","author":"DJ Hearse","year":"1998","unstructured":"Hearse, D. J. Myocardial protection during ischemia and reperfusion. Mol Cell Biochem \n                           186, 177\u2013184 (1998).","journal-title":"Mol Cell Biochem"},{"key":"9547_CR3","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/nm.2507","volume":"17","author":"KE Holger","year":"2011","unstructured":"Holger, K. E. & Tobias, E. Ischemia and reperfusion-from mechanism to translation. Nat Med \n                           17, 1391\u20131401 (2011).","journal-title":"Nat Med"},{"key":"9547_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0167-5273(96)02854-9","volume":"58","author":"RJM Simon","year":"1997","unstructured":"Simon, R. J. M. & Gregory, Y. H. L. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol \n                           58, 95\u2013117 (1997).","journal-title":"Int J Cardiol"},{"key":"9547_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI62874","volume":"123","author":"JH Derek","year":"2013","unstructured":"Derek, J. H. & Derek, M. Y. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. Clin Invest \n                           123, 92\u2013100 (2013).","journal-title":"Clin Invest"},{"key":"9547_CR6","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1161\/CIRCRESAHA.114.302804","volume":"114","author":"S Victor","year":"2014","unstructured":"Victor, S., William, E. B., Sidney, C. S. & Patrick, T. O. Non-antithrombotic medical options in ACS: old agents and new lines on the horizon. Circ Res \n                           114, 1944\u20131958 (2014).","journal-title":"Circ Res"},{"key":"9547_CR7","first-page":"129","volume":"6","author":"J Vohra","year":"1982","unstructured":"Vohra, J. Verapamil in cardiac arrhythmias: an overview. Clin Exp Pharmacol Physiol Suppl \n                           6, 129\u2013134 (1982).","journal-title":"Clin Exp Pharmacol Physiol Suppl"},{"key":"9547_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/bcp.12763","volume":"81","author":"A Graudins","year":"2016","unstructured":"Graudins, A., Lee, H. M. & Druda, D. Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies. Br J Clin Pharmacol \n                           81, 453\u2013461 (2016).","journal-title":"Br J Clin Pharmacol"},{"key":"9547_CR9","doi-asserted-by":"publisher","first-page":"H140","DOI":"10.1152\/ajpheart.00687.2008","volume":"296","author":"IK Mohan","year":"2009","unstructured":"Mohan, I. K. et al. Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction. Am J Physiol Heart Circ Physiol \n                           296, H140\u2013151 (2009).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9547_CR10","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.4103\/0366-6999.166026","volume":"128","author":"W Hua","year":"2015","unstructured":"Hua, W. et al. The efficacy and safety of Wenxin Keli in patients with frequent premature ventricular contractions: a randomized, double-blind, placebo-controlled, parallel-group, multicenter Trial. Chin Med J \n                           128, 2557\u20132564 (2015).","journal-title":"Chin Med J"},{"key":"9547_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.hrthm.2011.08.027","volume":"9","author":"A Burashnikov","year":"2012","unstructured":"Burashnikov, A., Petroski, A., Hu, D., Barajas-Martinez, H. & Antzelevitch, C. Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation. Heart Rhythm \n                           9, 125\u2013131 (2012).","journal-title":"Heart Rhythm"},{"key":"9547_CR12","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/pace.12109","volume":"36","author":"X Xue","year":"2013","unstructured":"Xue, X. et al. Wenxin Keli suppresses ventricular triggered arrhythmias via selective inhibition of late sodium current. Pacing ClinElectrophysiol \n                           36, 732\u2013740 (2013).","journal-title":"Pacing ClinElectrophysiol"},{"key":"9547_CR13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/mmr.2012.1195","volume":"7","author":"X Wang","year":"2013","unstructured":"Wang, X., Gu, Y., Wang, T. & Huang, C. Wenxin Keli attenuates ischemia-induced ventricular arrhythmias in rats: involvement of L-type calcium and transient outward potassium currents. Mol Med Rep \n                           7, 519\u2013524 (2013).","journal-title":"Mol Med Rep"},{"key":"9547_CR14","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.hrthm.2013.03.011","volume":"10","author":"Y Minoura","year":"2013","unstructured":"Minoura, Y. et al. Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome. Heart Rhythm \n                           10, 1054\u20131062 (2013).","journal-title":"Heart Rhythm"},{"key":"9547_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/464508","volume":"2013","author":"Y Xing","year":"2013","unstructured":"Xing, Y. et al. Wenxin-Keli regulates the calcium\/calmodulin-dependent protein kinase II signal transduction pathway and inhibits cardiac arrhythmia in rats with myocardial infarction. Evid Based Complement Alternat Med \n                           2013, 464508 (2013).","journal-title":"Evid Based Complement Alternat Med"},{"key":"9547_CR16","volume":"2016","author":"M Zheng","year":"2016","unstructured":"Zheng, M. et al. The effect of Wenxin Keli on the mRNA expression profile of rabbits with myocardial infarction. Evid Based Complement Alternat Med \n                           2016, 2352614 (2016).","journal-title":"Evid Based Complement Alternat Med"},{"key":"9547_CR17","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.2147\/DDDT.S112333","volume":"10","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. Systematic review and meta-analysis of randomized controlled trials on Wenxin keli. Drug Des Devel Ther \n                           10, 3725\u20133736 (2016).","journal-title":"Drug Des Devel Ther"},{"key":"9547_CR18","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/004982599238047","volume":"29","author":"JK Nicholson","year":"1999","unstructured":"Nicholson, J. K., Lindon, J. C. & Holmes, E. \u2018Metabonomics\u2019: the metabolic responses of living systems to pathophysiological stimuli. Xenobiotica \n                           29, 1181\u20131189 (1999).","journal-title":"Xenobiotica"},{"key":"9547_CR19","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1055\/s-0030-1250542","volume":"76","author":"A Zhang","year":"2010","unstructured":"Zhang, A. et al. Metabolomics: towards understanding traditional Chinese medicine. Planta Med \n                           76, 2026\u20132035 (2010).","journal-title":"Planta Med"},{"key":"9547_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1074\/mcp.M111.016006","volume":"11","author":"X Wang","year":"2012","unstructured":"Wang, X. et al. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics \n                           11, 370\u2013380 (2012).","journal-title":"Mol Cell Proteomics"},{"key":"9547_CR21","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1142\/S0192415X15500731","volume":"43","author":"P Wang","year":"2015","unstructured":"Wang, P., Wang, Q., Yang, B., Zhao, S. & Kuang, H. The Progress of metabolomics study in traditional Chinese medicine research. Am J Chin Med \n                           43, 1281\u20131310 (2015).","journal-title":"Am J Chin Med"},{"key":"9547_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/ptr.5240","volume":"29","author":"H Cao","year":"2015","unstructured":"Cao, H., Zhang, A., Zhang, H., Sun, H. & Wang, X. The application of metabolomics in traditional Chinese medicine opens up a dialogue between Chinese and Western medicine. Phytother Res \n                           29, 159\u2013166 (2015).","journal-title":"Phytother Res"},{"key":"9547_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1042\/BJ20042006","volume":"390","author":"G Solaini","year":"2005","unstructured":"Solaini, G. & Harris, D. A. Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem J \n                           390, 377\u2013394 (2005).","journal-title":"Biochem J"},{"key":"9547_CR24","first-page":"S3","volume":"12","author":"WC Stanley","year":"2001","unstructured":"Stanley, W. C. Cardiac energetics during ischaemia and the rationale for metabolic interventions. Coron Artery Dis \n                           12, S3\u20137 (2001).","journal-title":"Coron Artery Dis"},{"key":"9547_CR25","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/1891018a0","volume":"189","author":"JC Shipp","year":"1961","unstructured":"Shipp, J. C., Opie, L. H. & Challoner, D. Fatty acid and glucose metabolism in the perfused heart. Nature \n                           189, 1018\u20131019 (1961).","journal-title":"Nature"},{"key":"9547_CR26","first-page":"785","volume":"1","author":"PJ Randle","year":"1963","unstructured":"Randle, P. J., Garland, P. B., Hales, C. N. & Newsholme, E. A. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet \n                           1, 785\u2013789 (1963).","journal-title":"Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet"},{"key":"9547_CR27","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13909","volume":"515","author":"ET Chouchani","year":"2014","unstructured":"Chouchani, E. T. et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature \n                           515, 431\u2013435 (2014).","journal-title":"Nature"},{"key":"9547_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk, G. D., Ussher, J. R., Folmes, C. D., Jaswal, J. S. & Stanley, W. C. Myocardial fatty acid metabolism in health and disease. Physiol Rev \n                           90, 207\u2013258 (2010).","journal-title":"Physiol Rev"},{"key":"9547_CR29","doi-asserted-by":"crossref","unstructured":"Lopaschuk, G. D. & Dhalla, N. S. Cardiac Energy Metabolism in Health and Disease (Springer) 3\u201314 (New York, 2014).","DOI":"10.1007\/978-1-4939-1227-8"},{"key":"9547_CR30","unstructured":"Nelson, D. L. & Cox, M. M. Lehninger principles of biochemistry sixth edition (W. H. freeman and company) 699\u2013702 (New York, 2012)."},{"key":"9547_CR31","doi-asserted-by":"publisher","first-page":"18745","DOI":"10.1073\/pnas.0903032106","volume":"106","author":"DD Sears","year":"2009","unstructured":"Sears, D. D. et al. Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization. Proc Natl Acad Sci USA \n                           106, 18745\u201318750 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"9547_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-14-169","volume":"14","author":"PY Jin","year":"2014","unstructured":"Jin, P. Y., Zhang, H. S., Guo, X. Y., Liang, W. F. & Han, Q. F. Glucose-insulin-potassium therapy in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord \n                           14, 169 (2014).","journal-title":"BMC Cardiovasc Disord"},{"key":"9547_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0378-1097(03)00611-6","volume":"226","author":"GB Schuller-Levis","year":"2003","unstructured":"Schuller-Levis, G. B. & Park, E. Taurine: new implications for an old amino acid. FEMS Microbiol Lett \n                           226, 195\u2013202 (2003).","journal-title":"FEMS Microbiol Lett"},{"key":"9547_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00360-015-0946-0","volume":"186","author":"TJ MacCormack","year":"2016","unstructured":"MacCormack, T. J., Callaghan, N. I., Sykes, A. V. & Driedzic, W. R. Taurine depresses cardiac contractility and enhances systemic heart glucose utilization in the cuttlefish, Sepia officinalis. J Comp Physiol B \n                           186, 215\u2013227 (2016).","journal-title":"J Comp Physiol B"},{"key":"9547_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0304-4165(91)90187-L","volume":"1073","author":"TR Green","year":"1991","unstructured":"Green, T. R., Fellman, J. H., Eicher, A. L. & Pratt, K. L. Antioxidant role and subcellular location of hypotaurine and taurine in human neutrophils. Biochim Biophys Acta \n                           1073, 91\u201397 (1991).","journal-title":"Biochim Biophys Acta"},{"key":"9547_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00726-003-0002-3","volume":"26","author":"M Zhang","year":"2004","unstructured":"Zhang, M. et al. Role of taurine supplementation to prevent exercise-induced oxidative stress in healthy young men. Amino Acids \n                           26, 203\u2013207 (2004).","journal-title":"Amino Acids"},{"key":"9547_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10545-014-9704-9","volume":"37","author":"T Fukao","year":"2014","unstructured":"Fukao, T. et al. Ketone body metabolism and its defects. J Inherit Metab Dis \n                           37, 541\u2013551 (2014).","journal-title":"J Inherit Metab Dis"},{"key":"9547_CR38","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","volume":"133","author":"KC Bedi","year":"2016","unstructured":"Bedi, K. C. et al. Evidence for intra myocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure. Circulation \n                           133, 706\u2013716 (2016).","journal-title":"Circulation"},{"key":"9547_CR39","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/CIRCULATIONAHA.116.021230","volume":"133","author":"SC Kolwicz","year":"2016","unstructured":"Kolwicz, S. C., Airhart, S. & Tian, R. Ketones step to the plate: a game changer for metabolic remodeling in heart failure? Circulation \n                           133, 689\u2013691 (2016).","journal-title":"Circulation"},{"key":"9547_CR40","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.2147\/DDDT.S82146","volume":"9","author":"JR Chen","year":"2015","unstructured":"Chen, J. R. et al. Cardioprotection against ischemia\/reperfusion injury by QiShenYiQi Pill (R) via ameliorate of multiple mitochondrial dysfunctions. Drug Des Dev Ther \n                           9, 3051\u20133066 (2015).","journal-title":"Drug Des Dev Ther"},{"key":"9547_CR41","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jpba.2004.09.060","volume":"39","author":"LH Lucas","year":"2005","unstructured":"Lucas, L. H., Larive, C. K., Wilkinson, P. S. & Huhn, S. Progress toward automated metabolic profiling of human serum: comparison of CPMG and gradient-filtered NMR analytical methods. J Pharm Biomed Anal \n                           39, 156\u2013163 (2005).","journal-title":"J Pharm Biomed Anal"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09547-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09547-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09547-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T08:49:19Z","timestamp":1671785359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09547-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,18]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["9547"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-09547-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,18]]},"assertion":[{"value":"25 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8739"}}